MINA (HOLDINGS) LIMITED
Research and experimental development on biotechnology
MINA (HOLDINGS) LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Translation & Innovation Hub 84 Wood Lane London W12 0BZ United Kingdom
Full company profile for MINA (HOLDINGS) LIMITED (09293168), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 3 Nov 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2021–2024)
Cash in Bank
£861.19k
Net Assets
-£8.47M
Total Liabilities
£14.20M
Turnover
£1.55M
Employees
33
Debt Ratio
248%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 31 Dec Year End | 2022 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 5 funding rounds
Sign up to view complete fundraising history
Investors (5)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Nov 2017 | Series A |
| Investor 2 | May 2019 | Series A |
| Investor 4 | Jul 2021 | Series A |
See all 5 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Robert Sebastian Habib | Director | British | United Kingdom | 3 Nov 2014 | Active |
| Susan Elizabeth Clement-davies | Director | British | England | 1 Jan 2022 | Active |
See all 14 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Robert Kopple
American
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Stephanie Galantine-heller
French
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Heptares Therapeutics Limited
Ceased 4 Aug 2020
Yair Chaim Schindel
Ceased 17 Feb 2025
Sosei R&d Limited
Ceased 29 Nov 2018
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 10 Mar 2026 | Capital | Allotment of shares (GBP 9,903.514) on 2 Feb 2026 | |
| 5 Jan 2026 | Officers | Change to director Dr. Norbert Wolfgang Bischofberger on 5 Jan 2026 | |
| 27 Dec 2025 | Persons With Significant Control | Change to Mr Robert Charles Kopple as a person with significant control on 24 Dec 2025 | |
| 24 Dec 2025 | Capital | Allotment of shares (GBP 9,902.639) on 11 Dec 2025 | |
| 24 Dec 2025 | Officers | Change to director Mr Robert Charles Kopple on 24 Dec 2025 |
Allotment of shares (GBP 9,903.514) on 2 Feb 2026
Change to director Dr. Norbert Wolfgang Bischofberger on 5 Jan 2026
Change to Mr Robert Charles Kopple as a person with significant control on 24 Dec 2025
Allotment of shares (GBP 9,902.639) on 11 Dec 2025
Change to director Mr Robert Charles Kopple on 24 Dec 2025
Recent Activity
Latest Activity
Allotment of shares (GBP 9,903.514) on 2 Feb 2026
3 months ago on 10 Mar 2026
Change to director Dr. Norbert Wolfgang Bischofberger on 5 Jan 2026
5 months ago on 5 Jan 2026
Change to Mr Robert Charles Kopple as a person with significant control on 24 Dec 2025
5 months ago on 27 Dec 2025
Allotment of shares (GBP 9,902.639) on 11 Dec 2025
5 months ago on 24 Dec 2025
Change to director Mr Robert Charles Kopple on 24 Dec 2025
5 months ago on 24 Dec 2025